Literature DB >> 18539227

Induced hypothermia and fever control for prevention and treatment of neurological injuries.

Kees H Polderman1.   

Abstract

Increasing evidence suggests that induction of mild hypothermia (32-35 degrees C) in the first hours after an ischaemic event can prevent or mitigate permanent injuries. This effect has been shown most clearly for postanoxic brain injury, but could also apply to other organs such as the heart and kidneys. Hypothermia has also been used as a treatment for traumatic brain injury, stroke, hepatic encephalopathy, myocardial infarction, and other indications. Hypothermia is a highly promising treatment in neurocritical care; thus, physicians caring for patients with neurological injuries, both in and outside the intensive care unit, are likely to be confronted with questions about temperature management more frequently. This Review discusses the available evidence for use of controlled hypothermia, and also deals with fever control. Besides discussing the evidence, the aim is to provide information to help guide treatments more effectively with regard to timing, depth, duration, and effective management of side-effects. In particular, the rate of rewarming seems to be an important factor in establishing successful use of hypothermia in the treatment of neurological injuries.

Entities:  

Mesh:

Year:  2008        PMID: 18539227     DOI: 10.1016/S0140-6736(08)60837-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  150 in total

1.  Fever control and application of hypothermia using intravenous cold saline.

Authors:  Ericka L Fink; Patrick M Kochanek; Robert S B Clark; Michael J Bell
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

Review 2.  [Therapy of head trauma].

Authors:  K Engelhard; W Müller-Forell; C Werner
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

Review 3.  Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling.

Authors:  Wolfgang Löscher; Andrew J Cole; Michael J McLean
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 4.  Therapeutic hypothermia for cardiac arrest: a practical approach.

Authors:  David B Seder; Salam Jarrah
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

5.  Post-traumatic seizure susceptibility is attenuated by hypothermia therapy.

Authors:  Coleen M Atkins; Jessie S Truettner; George Lotocki; Juliana Sanchez-Molano; Yuan Kang; Ofelia F Alonso; Thomas J Sick; W Dalton Dietrich; Helen M Bramlett
Journal:  Eur J Neurosci       Date:  2010-10-29       Impact factor: 3.386

Review 6.  Management of intracranial pressure.

Authors:  Thomas J Wolfe; Michel T Torbey
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 7.  Temperature management for out-of-hospital cardiac arrest.

Authors:  Patrick J Coppler; Cameron Dezfulian; Jonathan Elmer; Jon C Rittenberger
Journal:  JAAPA       Date:  2017-12

8.  Mild hypothermia alleviates excessive autophagy and mitophagy in a rat model of asphyxial cardiac arrest.

Authors:  Jian Lu; Hui-Yin Qian; Li-Jun Liu; Bao-Chun Zhou; Yan Xiao; Jin-Ning Mao; Guo-Yin An; Ming-Zhong Rui; Tao Wang; Chang-Lai Zhu
Journal:  Neurol Sci       Date:  2014-05-11       Impact factor: 3.307

9.  Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome.

Authors:  Pierre Esnault; Cédric Nguyen; Julien Bordes; Erwan D'Aranda; Ambroise Montcriol; Claire Contargyris; Jean Cotte; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Henry Boret; Eric Meaudre
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

10.  THE EFFECTS OF POSTTRAUMATIC HYPOTHERMIA ON DIFFUSE AXONAL INJURY FOLLOWING PARASAGGITAL FLUID PERCUSSION BRAIN INJURY IN RATS.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2012-03       Impact factor: 1.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.